Portland, OR 的 淋巴瘤 臨床試驗
9 項針對 淋巴瘤 的研究正在 Portland（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
招募中1/2 期
- Oregon Health and Sciences University, Portland
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
招募中1 期
- Oregon Health & Science University, Portland
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
招募中1/2 期
- Oregon Health and Science University, Portland
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
招募中1/2 期
- Oregon Health & Science University, Portland
DALY II USA/ MB-CART2019.1 for DLBCL
招募中2 期
- Oregon Health and Science University Knight Cancer Institute, Portland
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
招募中觀察性研究
- Legacy Emanuel Children's Hospital, Portland
- Oregon Health and Science University, Portland
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
招募中1/2 期
- Providence Neurological Specialties West, Portland
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
招募中2 期
- Oregon Health & Science University, Portland
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
招募中觀察性研究歡迎健康志工
- Oregon Health Sciences University, Portland
其他城市的 淋巴瘤 試驗
- Houston, TX34 項研究
- Boston, MA33 項研究
- New York City, NY33 項研究
- Washington, DC23 項研究
- Baldwin Park, CA21 項研究
- Chicago, IL20 項研究
- Durham, NC17 項研究
- St. Louis, MO15 項研究
- Philadelphia, PA15 項研究
- Cleveland, OH14 項研究
- Edison, NJ12 項研究
- Atlanta, GA12 項研究
Portland 的其他研究
- 非小細胞肺癌46 項研究
- 癌症（所有類型）34 項研究
- 前列腺癌33 項研究
- 乳癌33 項研究
- 轉移性癌症29 項研究
- 大腸直腸癌28 項研究
- 卵巢癌27 項研究
- 肺癌26 項研究
- 急性髓系白血病25 項研究
- 子宮內膜癌24 項研究
- 頭頸部鱗狀細胞癌19 項研究
- 胰臟癌19 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。